These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2073671

  • 1. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.
    Ojala JP, Helve E, Tikkanen MJ.
    Cardiology; 1990; 77 Suppl 4():39-49. PubMed ID: 2073671
    [Abstract] [Full Text] [Related]

  • 2. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
    McKenney JM, Barnett MD, Wright JT, Proctor JP.
    Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
    [Abstract] [Full Text] [Related]

  • 3. Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study.
    Tikkanen MJ, Helve E, Jäättelä A, Kaarsalo E, Lehtonen A, Malbecq W, Oksa H, Pääkkönen P, Salmi J, Veharanta T.
    Am J Cardiol; 1988 Nov 11; 62(15):35J-43J. PubMed ID: 3055922
    [Abstract] [Full Text] [Related]

  • 4. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 5. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.
    Metabolism; 1999 Jan 15; 48(1):47-54. PubMed ID: 9920144
    [Abstract] [Full Text] [Related]

  • 6. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB, Kannel WB, Stepanians MN, D'Agostino LC.
    Am J Cardiol; 1992 Jan 01; 69(1):28-34. PubMed ID: 1729864
    [Abstract] [Full Text] [Related]

  • 7. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E, De Gennes JL, Malbecq W, Baigts F.
    Clin Cardiol; 1995 Nov 01; 18(11):621-9. PubMed ID: 8590530
    [Abstract] [Full Text] [Related]

  • 9. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
    Bredie SJ, Westerveld HT, Knipscheer HC, de Bruin TW, Kastelein JJ, Stalenhoef AF.
    Neth J Med; 1996 Aug 01; 49(2):59-67. PubMed ID: 8824106
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
    Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Didangelos TP, Carina MV, Kranitsas DF, Kontopoulos AG.
    Am J Cardiol; 1997 Sep 01; 80(5):608-13. PubMed ID: 9294990
    [Abstract] [Full Text] [Related]

  • 11. A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    Vallés F, Anguita M, Anglada J, Aguirre C, Fabiani F, Plaza L, Soriguer F, Azanza JR, Barcina C.
    Atherosclerosis; 1991 Dec 01; 91 Suppl():S3-9. PubMed ID: 1789815
    [Abstract] [Full Text] [Related]

  • 12. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.
    Bell DS.
    Clin Ther; 1995 Dec 01; 17(5):901-10. PubMed ID: 8595642
    [Abstract] [Full Text] [Related]

  • 13. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR, Bacon S.
    Circulation; 1989 Mar 01; 79(3):590-6. PubMed ID: 2645064
    [Abstract] [Full Text] [Related]

  • 14. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M, López de Ocáriz A, Alvarez MP, Ariño M, Azanza JR, Honorato J.
    Rev Med Univ Navarra; 1992 Mar 01; 37(3):127-33. PubMed ID: 1480917
    [Abstract] [Full Text] [Related]

  • 15. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL, Grundy SM.
    JAMA; 1989 Dec 08; 262(22):3148-53. PubMed ID: 2810673
    [Abstract] [Full Text] [Related]

  • 16. Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial.
    Rabkin SW, Hayden M, Frohlich J.
    Atherosclerosis; 1988 Oct 08; 73(2-3):233-40. PubMed ID: 3056431
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC.
    Br J Clin Pharmacol; 1998 Mar 08; 45(3):265-9. PubMed ID: 9517370
    [Abstract] [Full Text] [Related]

  • 18. Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia.
    Ramires JA, Mansur AP, Solimene MC, Maranhão R, Chamone D, da Luz P, Pileggi F.
    Int J Cardiol; 1995 Feb 08; 48(2):115-20. PubMed ID: 7774989
    [Abstract] [Full Text] [Related]

  • 19. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 20. Management of primary mixed hyperlipidemia with lovastatin.
    Vega GL, Grundy SM.
    Arch Intern Med; 1990 Jun 15; 150(6):1313-9. PubMed ID: 2353864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.